<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04449263</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-109</org_study_id>
    <nct_id>NCT04449263</nct_id>
  </id_info>
  <brief_title>Comparing the Performance of 1 Day Multifocal Contact Lenses</brief_title>
  <official_title>Comparing the Performance of 1 Day Multifocal Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to compare the lens handling and performance of Lens A to
      habitually worn multifocal contact lenses and to the competitor Lens B.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the study is to compare the lens handling and performance of Lens A to
      habitually worn multifocal contact lenses and to the competitor Lens B. This is a
      prospective, randomized, participant-masked, crossover, bilateral dispensing study conducted
      at up to 5 clinical practice sites in the United States. Each lens type will be worn for up
      to 3 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 15, 2020</start_date>
  <completion_date type="Anticipated">November 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective at-home ratings of Lens handling for insertion</measure>
    <time_frame>13 Days</time_frame>
    <description>Subjective at-home ratings of Lens handling for insertion will be assessed using a 0-10 scale,</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>Lens A (Test) then Lens B (Control)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be randomized to wear Lens A (test) then Lens B (control) for 3 weeks in this randomized, cross-over bilateral dispensing study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lens B (Control) then Lens A (Test)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will be randomized to wear Lens B (control) then Lens A (test) for 3 weeks in this randomized, cross-over bilateral dispensing study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lens A</intervention_name>
    <description>Subjects will be randomized to wear Lens A (test) for 3 weeks.</description>
    <arm_group_label>Lens A (Test) then Lens B (Control)</arm_group_label>
    <arm_group_label>Lens B (Control) then Lens A (Test)</arm_group_label>
    <other_name>stenfilcon A</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lens B</intervention_name>
    <description>Subjects will be randomized to wear Lens B (control) for 3 weeks.</description>
    <arm_group_label>Lens A (Test) then Lens B (Control)</arm_group_label>
    <arm_group_label>Lens B (Control) then Lens A (Test)</arm_group_label>
    <other_name>delefilcon A</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Is at least 42 years of age and has full legal capacity to volunteer;

          2. Has read and signed an information consent letter;

          3. Self reports having a full eye examination in the previous two years;

          4. Anticipates being able to wear the study lenses for at least 8 hours a day, 5 days a
             week;

          5. Is willing and able to follow instructions and maintain the appointment schedule;

          6. Habitually wears multifocal soft contact lenses, for the past 3 months minimum;

          7. Has refractive astigmatism no higher than -0.75DC;

          8. Is presbyopic and requires a reading addition of at least +0.75D and no more than
             +2.50D;

          9. Can be fit and achieve binocular distance vision of at least 20/30 Snellen (or +0.20
             logMAR) which participants also deem to be 'acceptable', with the available study lens
             parameters (sphere +4 to -6; near addition or LOW, MEDIUM, HIGH).

        Exclusion Criteria:

          1. Is participating in any concurrent clinical or research study;

          2. Habitually wears one of the study contact lenses;

          3. Has any known active* ocular disease and/or infection that contraindicates contact
             lens wear;

          4. Has a systemic condition that in the opinion of the investigator may affect a study
             outcome variable;

          5. Is using any systemic or topical medications that in the opinion of the investigator
             may affect contact lens wear or a study outcome variable;

          6. Has known sensitivity to the diagnostic sodium fluorescein used in the study;

          7. Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;

          8. Has undergone refractive error surgery or intraocular surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>42 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wayne Golden</last_name>
    <role>Principal Investigator</role>
    <affiliation>Golden Vision</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Keith Wan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Scripps Poway Eyecare</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shane Kannarr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kannarr Eye Care</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Ardaya</last_name>
    <role>Principal Investigator</role>
    <affiliation>Golden Optometric Group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katherine Bickle</last_name>
    <role>Principal Investigator</role>
    <affiliation>ProCare Vision Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose A. Vega, O.D., MSc., FAAO</last_name>
    <phone>925 621 3761</phone>
    <email>javega@coopervision.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Scripps Poway Eyecare</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92131</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Keith Wan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Golden Optometric Group</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <zip>90606</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>David Ardaya</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Golden Vision</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34237</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Wayne Golden</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kannarr Eye Care</name>
      <address>
        <city>Pittsburg</city>
        <state>Kansas</state>
        <zip>66762</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Shane Kannarr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ProCare Vision Center</name>
      <address>
        <city>Granville</city>
        <state>Ohio</state>
        <zip>43023</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Katherine Bickle</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 24, 2020</study_first_submitted>
  <study_first_submitted_qc>June 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2020</study_first_posted>
  <last_update_submitted>June 24, 2020</last_update_submitted>
  <last_update_submitted_qc>June 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

